Literature DB >> 18224668

Diagnostic value of integrin alpha3, beta4, and beta5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma.

Akira Kurokawa1, Masaki Nagata, Nobutaka Kitamura, Arhab A Noman, Makoto Ohnishi, Tokio Ohyama, Takanori Kobayashi, Susumu Shingaki, Ritsuo Takagi.   

Abstract

BACKGROUND: The objective of the current study was to identify biomarkers that reflect the clinical course of squamous cell carcinoma of the tongue (TSCC).
METHODS: TSCC tissue samples from 66 patients were subjected to gene expression analysis by real-time polymerase chain reaction. Eleven integrin family genes and 14 genes used for normalization, including housekeeping genes and genes that encode desmosomal, cytoskeletal, and extracellular matrix molecules, were considered. Multivariate statistical analysis was performed on 154 expression ratios of integrin genes with clinical parameters.
RESULTS: In principal-component analysis, the first principal component was related to the outcome of death, and the second principal component mainly reflected the tendency for cervical lymph node (LN) metastasis. The former axis consisted of the variance of the integrin beta4 gene (ITGB4) and ITGB5 expression levels, and the latter axis agreed with the expression level of the integrin alpha3 gene (ITGA3). Multivariate logistic regression analysis with cervical LN metastasis as the response variable concordantly identified ITGA3/junction plakoglobin gene (JUP) expression (P=.02) and ITGB5/paxillin gene (PXN) expression (P=.04) as significant factors. Only ITGB4/JUP expression was identified as a significant factor in terms of the outcome of death (P<.00049) by a Cox proportional hazards model. The group with high ITGB4/JUP levels exhibited a significantly high death rate on a Kaplan-Meier curve (P<.0001; Wilcoxon and log-rank tests).
CONCLUSIONS: The expression levels of ITGA3, ITGB4, and ITGB5 with functional normalization by desmosomal or cytoskeletal molecule genes were selected as candidate biomarkers for cervical LN metastasis or for the outcome of death in TSCC. Copyright (c) 2008 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18224668     DOI: 10.1002/cncr.23295

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

1.  Single-nucleotide polymorphisms of integrins are associated with the risk and lymph node metastasis of oral squamous cell carcinoma.

Authors:  Xiang-Rui Ma; Hui Cheng; Xiao-Yi Wang; Hao Liu; Dan Zhao
Journal:  Med Oncol       Date:  2012-01-21       Impact factor: 3.064

2.  Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.

Authors:  Haijun Zhang; Fanyan Meng; Gang Liu; Bin Zhang; Jun Zhu; Feng Wu; Stephen P Ethier; Fred Miller; Guojun Wu
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

Review 3.  Clinical significance of the integrin α6β4 in human malignancies.

Authors:  Rachel L Stewart; Kathleen L O'Connor
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

4.  Bufalin inhibits glycolysis-induced cell growth and proliferation through the suppression of Integrin β2/FAK signaling pathway in ovarian cancer.

Authors:  Haoran Li; Shuang Hu; Yangyang Pang; Mengjiao Li; Lihua Chen; Fei Liu; Mingming Liu; Ziliang Wang; Xi Cheng
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

5.  Diagnostic value of cyclin-dependent kinase/cyclin-dependent kinase inhibitor expression ratios as biomarkers of locoregional and hematogenous dissemination risks in oral squamous cell carcinoma.

Authors:  Masaki Nagata; Hiroshi Kurita; Kohya Uematsu; Shin Ogawa; Katsu Takahashi; Hideyuki Hoshina; Ritsuo Takagi
Journal:  Mol Clin Oncol       Date:  2015-06-10

6.  Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma.

Authors:  Y Masugi; K Yamazaki; K Emoto; K Effendi; H Tsujikawa; M Kitago; O Itano; Y Kitagawa; M Sakamoto
Journal:  Lab Invest       Date:  2015-01-19       Impact factor: 5.662

7.  Expression of integrin-alpha(3) mRNA in meningiomas and its correlation with proliferation and invasion.

Authors:  Jian Chen; Xianping Xu; Heping Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

8.  Cisplatin suppresses the growth and proliferation of breast and cervical cancer cell lines by inhibiting integrin β5-mediated glycolysis.

Authors:  Shaojia Wang; Jie Xie; Jiajia Li; Fei Liu; Xiaohua Wu; Ziliang Wang
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

Review 9.  Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets.

Authors:  Christopher S Stipp
Journal:  Expert Rev Mol Med       Date:  2010-01-18       Impact factor: 5.600

10.  ITGA3 Is Associated With Immune Cell Infiltration and Serves as a Favorable Prognostic Biomarker for Breast Cancer.

Authors:  Yue Li; Fan Li; Xiaoyu Bai; Yanlei Li; Chunsheng Ni; Xiulan Zhao; Danfang Zhang
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.